Skip to main navigation Skip to search Skip to main content

Novel antimicrobial strategies to treat multi-drug resistant Staphylococcus aureus infections

  • Edward J A Douglas*
  • , Sri W Wulandari
  • , Scott D Lovell
  • , Maisem Laabei*
  • *Corresponding author for this work

    Research output: Contribution to journal › Review article (Academic Journal) › peer-review

    70 Citations (Scopus)

    Abstract

    Antimicrobial resistance is a major obstacle for the treatment of infectious diseases and currently represents one of the most significant threats to global health. Staphylococcus aureus remains a formidable human pathogen with high mortality rates associated with severe systemic infections. S. aureus has become notorious as a multidrug resistant bacterium, which when combined with its extensive arsenal of virulence factors that exacerbate disease, culminates in an incredibly challenging pathogen to treat clinically. Compounding this major health issue is the lack of antibiotic discovery and development, with only two new classes of antibiotics approved for clinical use in the last 20 years. Combined efforts from the scientific community have reacted to the threat of dwindling treatment options to combat S. aureus disease in several innovative and exciting developments. This review describes current and future antimicrobial strategies aimed at treating staphylococcal colonization and/or disease, examining therapies that show significant promise at the preclinical development stage to approaches that are currently being investigated in clinical trials.

    Original languageEnglish
    Pages (from-to)1456-1474
    Number of pages19
    JournalMicrobial Biotechnology
    Volume16
    Issue number7
    Early online date13 May 2023
    DOIs
    Publication statusPublished - 20 Jun 2023

    Bibliographical note

    Publisher Copyright:
    © 2023 The Authors. Microbial Biotechnology published by Applied Microbiology International and John Wiley & Sons Ltd.

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Drug Resistance, Multiple, Bacterial
    • Staphylococcus aureus
    • Antimicrobial Cationic Peptides
    • Biological Products/therapeutic use
    • Anti-Bacterial Agents/therapeutic use
    • Adjuvants, Pharmaceutic/therapeutic use
    • Drug Synergism
    • Immunoconjugates/therapeutic use
    • Phage Therapy
    • Drug Development/trends
    • Staphylococcal Infections/drug therapy
    • Humans

    Fingerprint

    Dive into the research topics of 'Novel antimicrobial strategies to treat multi-drug resistant Staphylococcus aureus infections'. Together they form a unique fingerprint.

    Cite this